Quantitative changes in skin composition parameters due to chemotherapy in breast cancer patients: a cohort study
- PMID: 26198993
- DOI: 10.1007/s10549-015-3502-4
Quantitative changes in skin composition parameters due to chemotherapy in breast cancer patients: a cohort study
Abstract
The objective of this study is to evaluate objective changes in water content, sebum content, transepidermal water loss (TEWL), and melanin due to breast cancer chemotherapy, and their association with subjective symptoms. Prospective cohort study of 61 patients 18 years of age or older with a postoperative diagnosis of stage I-III breast cancer, who received adjuvant chemotherapy between February and September 2012 at an outpatient breast cancer clinic in Korea. Objective skin parameters, measured using a noninvasive bioengineering device, and patient-reported dryness and dullness were assessed before chemotherapy, after two cycles of chemotherapy, and 1, 3, and 6 months after completion of chemotherapy. Water content (-6.5 %), sebum (-75.5 %), and TEWL (-22.4 %) significantly decreased during chemotherapy compared to pre-chemotherapy levels (all p values <0.001). These parameters were lowest at 1 month after completion of chemotherapy and recovered thereafter but did not return to baseline levels after 6 months of follow-up. Melanin increased during chemotherapy with respect to pre-chemotherapy levels (8.4 %; p < 0.001) but decreased from the first month after completion of chemotherapy through the end of follow-up (-17.1 %; p < 0.001). The patterns of skin changes were similar in patients with or without hormone therapy. Most of patients reported dryness (57.9 %) and dullness (49.1 %) after chemotherapy, and patient-reported dryness was significantly associated with decreased sebum content. Chemotherapy-induced substantial changes in objective skin composition parameters. These changes persisted after 6 months from completion of chemotherapy and were associated with patient-reported symptoms. Additional research is needed to translate these findings into interventions for improving the dermatologic quality of life of breast cancer patients undergoing chemotherapy.
Similar articles
-
Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer.Menopause. 2011 Nov;18(11):1244-8. doi: 10.1097/gme.0b013e31821b849b. Menopause. 2011. PMID: 21814159
-
Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo controlled study.Clin Endocrinol (Oxf). 2006 Nov;65(5):579-85. doi: 10.1111/j.1365-2265.2006.02631.x. Clin Endocrinol (Oxf). 2006. PMID: 17054457 Clinical Trial.
-
Quantitative Changes in Skin Composition Parameters after Radiation Therapy According to Surgery Types Among Patients with Breast Cancer: A Prospective Study.Clin Breast Cancer. 2022 Feb;22(2):e224-e231. doi: 10.1016/j.clbc.2021.06.013. Epub 2021 Jul 19. Clin Breast Cancer. 2022. PMID: 34400081
-
Health-related quality of life in early breast cancer.Dan Med Bull. 2010 Sep;57(9):B4184. Dan Med Bull. 2010. PMID: 20816024
-
[Observation and clinical significance of adjuvant chemotherapy-induced amenorrhea in premenopausal breast cancer patients].Zhonghua Zhong Liu Za Zhi. 2006 Nov;28(11):848-51. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17416008 Chinese.
Cited by
-
Reduced skin lipid content in obese Japanese women mediated by decreased expression of rate-limiting lipogenic enzymes.PLoS One. 2018 Mar 8;13(3):e0193830. doi: 10.1371/journal.pone.0193830. eCollection 2018. PLoS One. 2018. PMID: 29518109 Free PMC article.
-
Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy.J Pain Symptom Manage. 2018 Jan;55(1):39-55. doi: 10.1016/j.jpainsymman.2017.08.008. Epub 2017 Aug 31. J Pain Symptom Manage. 2018. PMID: 28838866 Free PMC article.
-
Decreased expression of hyaluronan synthase and loss of hyaluronan-rich cells in the anterior tibial fascia of the rat model of chemotherapy-induced peripheral neuropathy.Pain Rep. 2023 Jun 27;8(4):e1088. doi: 10.1097/PR9.0000000000001088. eCollection 2023 Jul-Aug. Pain Rep. 2023. PMID: 37388408 Free PMC article.
-
Cancer-Related Alopecia: From Etiologies to Global Management.Cancers (Basel). 2021 Nov 5;13(21):5556. doi: 10.3390/cancers13215556. Cancers (Basel). 2021. PMID: 34771716 Free PMC article. Review.
-
Case report: Improving quality of life through hyaluronic acid-based fillers after orbital cancer treatment.Front Oncol. 2024 Dec 18;14:1501556. doi: 10.3389/fonc.2024.1501556. eCollection 2024. Front Oncol. 2024. PMID: 39744006 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical